from the California Horse Racing Board

Sacramento, CA — On July 17, the California Horse Racing Board adopted a regulatory amendment moving stanozolol, boldenone, nandrolone, and testosterone from Class 4 to Class 3 and from Category D to Category B penalties. The California Office of Administrative Law now has completed its review and given final State approval to that regulatory amendment.

The CHRB will begin enforcement of the amended rule with races run September 4, 2008, and thereafter. Stanzolol, boldenone, nandrolone, and testosterone will be Class 3 substances with Category B penalties, and the presence of any of these anabolic steroids in the post-race sample above the authorized levels of 1844 (e) (10-14) will result in the automatic disqualification of the horse and redistribution of the purse. Category B penalties call for a minimum 30-day suspension and a fine up to $10,000.

Through September 3, 2008, stanozolol, boldenone, nandrolone, and testosterone will remain Class 4 violations and Category D penalties. All other anabolic steroids have been Class 2 or Class 3 violations and Category B penalties since July 1, 2008.